These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32811625)

  • 61. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
    Wu LT; Zhu H; Mannelli P; Swartz MS
    Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use.
    Budney AJ; Sofis MJ; Borodovsky JT
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):73-86. PubMed ID: 30604051
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Moderators and mediators of a maternal depression treatment study: Impact of maternal trauma and parenting on child outcomes.
    Swartz HA; Cyranowski JM; Cheng Y; Amole M
    Compr Psychiatry; 2018 Oct; 86():123-130. PubMed ID: 30118995
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Patterns of cannabis use and prospective associations with health issues among young males.
    Baggio S; N'Goran AA; Deline S; Studer J; Dupuis M; Henchoz Y; Mohler-Kuo M; Daeppen JB; Gmel G
    Addiction; 2014 Jun; 109(6):937-45. PubMed ID: 24450535
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multidimensional family therapy decreases the rate of externalising behavioural disorder symptoms in cannabis abusing adolescents: outcomes of the INCANT trial.
    Schaub MP; Henderson CE; Pelc I; Tossmann P; Phan O; Hendriks V; Rowe C; Rigter H
    BMC Psychiatry; 2014 Jan; 14():26. PubMed ID: 24485347
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Altered cortical maturation in adolescent cannabis users with and without schizophrenia.
    Epstein KA; Kumra S
    Schizophr Res; 2015 Mar; 162(1-3):143-52. PubMed ID: 25600549
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Executive attention impairment in adolescents with schizophrenia who have used cannabis.
    Epstein KA; Kumra S
    Schizophr Res; 2014 Aug; 157(1-3):48-54. PubMed ID: 24875171
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States.
    Patel RS; Goyal H; Satodiya R; Tankersley WE
    Subst Use Misuse; 2020; 55(2):281-290. PubMed ID: 31573379
    [No Abstract]   [Full Text] [Related]  

  • 69. Pilot trial of a telehealth-delivered behavioral economic intervention promoting cannabis-free activities among adults with cannabis use disorder.
    Coughlin LN; Bonar EE; Wieringa J; Zhang L; Rostker MJ; Augustiniak AN; Goodman GJ; Lin LA
    J Psychiatr Res; 2023 Jul; 163():202-210. PubMed ID: 37224772
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Is Cannabis Use Associated With the Worst Inpatient Outcomes in Attention Deficit Hyperactivity Disorder Adolescents?
    Patel RS; Patel P; Shah K; Kaur M; Mansuri Z; Makani R
    Cureus; 2018 Jan; 10(1):e2033. PubMed ID: 29535906
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Influence of cannabis use on suicidal ideations among 491 high-school students].
    Chabrol H; Mabila JD; Chauchard E
    Encephale; 2008 Jun; 34(3):270-3. PubMed ID: 18558148
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.
    Cooper K; Chatters R; Kaltenthaler E; Wong R
    Health Technol Assess; 2015 Jul; 19(56):1-130. PubMed ID: 26202542
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
    Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
    J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept.
    Wolitzky-Taylor K; Glasner S; Tanner A; Ghahremani DG; London ED
    Behav Res Ther; 2022 Mar; 150():104032. PubMed ID: 35032700
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood.
    Degenhardt L; Coffey C; Romaniuk H; Swift W; Carlin JB; Hall WD; Patton GC
    Addiction; 2013 Jan; 108(1):124-33. PubMed ID: 22775447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Goal commitment predicts cannabis use for adolescents in treatment.
    Kaminer Y; Ohannessian CM; Burke RH
    Subst Abus; 2019; 40(4):496-500. PubMed ID: 30810498
    [No Abstract]   [Full Text] [Related]  

  • 77. Intellectual, neurocognitive, and academic achievement in abstinent adolescents with cannabis use disorder.
    Hooper SR; Woolley D; De Bellis MD
    Psychopharmacology (Berl); 2014 Apr; 231(8):1467-77. PubMed ID: 24619597
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Item response theory analysis of lifetime cannabis-use disorder symptom severity in an American Indian community sample.
    Gilder DA; Lau P; Ehlers CL
    J Stud Alcohol Drugs; 2009 Nov; 70(6):839-49. PubMed ID: 19895760
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The association between lifetime cannabis use and dysthymia across six birth decades.
    Livne O; Razon L; Rehm J; Hasin DS; Lev-Ran S
    J Affect Disord; 2018 Jul; 234():327-334. PubMed ID: 29605793
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study.
    Milin R; Manion I; Dare G; Walker S
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):174-179. PubMed ID: 18176332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.